Company Filing History:
Years Active: 2012-2017
Title: Nancy Yuk Yu Ip: Innovator in Neuroprotective Agents
Introduction
Nancy Yuk Yu Ip is a prominent inventor based in Hong Kong, CN. She has made significant contributions to the field of neuroprotective agents, particularly in relation to neurodegenerative disorders. With a total of 3 patents, her work focuses on innovative therapeutic methods and agents that address critical health issues.
Latest Patents
One of her latest patents involves EphA4 inhibitors as neuroprotective agents. This invention provides insights into the role of EphA4 signaling in neurodegenerative disorders, particularly those involving β-amyloid induced neurotoxicity, such as Alzheimer's Disease. The patent outlines new therapeutic methods, agents, and kits for treating diseases caused or exacerbated by overactivated EphA4 signaling. Additionally, it includes methods for identifying further compounds that can serve as therapeutic agents for conditions linked to overly active EphA4 signaling. Another significant patent relates to a composition for treating neurodegenerative diseases or neuropathological conditions. This invention focuses on extracts and refined fractions of a traditional Chinese medicinal herb, along with their components, to treat neurodegenerative or neuropathological conditions and to inhibit the aggregation of α-synuclein.
Career Highlights
Nancy Yuk Yu Ip is affiliated with The Hong Kong University of Science and Technology, where she continues her research and innovation in the field of neuroprotection. Her work has garnered attention for its potential impact on treating debilitating neurological conditions.
Collaborations
She collaborates with notable colleagues, including Fanny Chui Fun Ip and Kit Yu Fu, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Nancy Yuk Yu Ip stands out as a leading inventor in the realm of neuroprotective agents, with her patents paving the way for new therapeutic approaches to combat neurodegenerative diseases. Her contributions are vital in advancing medical science and improving patient outcomes.